NL166018B - PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, AND FOR PREPARATIONS PREPARED USING THIS PROCESS AND METHOD FOR PREPARING SUITABLE COMPOUNDS. - Google Patents

PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, AND FOR PREPARATIONS PREPARED USING THIS PROCESS AND METHOD FOR PREPARING SUITABLE COMPOUNDS.

Info

Publication number
NL166018B
NL166018B NL7010668A NL7010668A NL166018B NL 166018 B NL166018 B NL 166018B NL 7010668 A NL7010668 A NL 7010668A NL 7010668 A NL7010668 A NL 7010668A NL 166018 B NL166018 B NL 166018B
Authority
NL
Netherlands
Prior art keywords
preparation
suitable compounds
preparations prepared
preparing suitable
pharmaceutical preparation
Prior art date
Application number
NL7010668A
Other languages
Dutch (nl)
Other versions
NL166018C (en
NL7010668A (en
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NL7010668A publication Critical patent/NL7010668A/xx
Publication of NL166018B publication Critical patent/NL166018B/en
Application granted granted Critical
Publication of NL166018C publication Critical patent/NL166018C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/44Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
NL7010668A 1969-08-08 1970-07-17 PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, AND FOR PREPARATIONS PREPARED USING THIS PROCESS AND METHOD FOR PREPARING SUITABLE COMPOUNDS. NL166018C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84873969A 1969-08-08 1969-08-08

Publications (3)

Publication Number Publication Date
NL7010668A NL7010668A (en) 1971-02-10
NL166018B true NL166018B (en) 1981-01-15
NL166018C NL166018C (en) 1981-06-15

Family

ID=25304142

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7010668A NL166018C (en) 1969-08-08 1970-07-17 PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, AND FOR PREPARATIONS PREPARED USING THIS PROCESS AND METHOD FOR PREPARING SUITABLE COMPOUNDS.

Country Status (6)

Country Link
BE (1) BE754587A (en)
BR (1) BR6915179D0 (en)
DE (1) DE2034640C3 (en)
FR (1) FR2068477B1 (en)
GB (1) GB1268469A (en)
NL (1) NL166018C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1416872A (en) * 1972-03-10 1975-12-10 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
FR2228482B1 (en) * 1973-05-11 1976-05-14 Roussel Uclaf
ZA743269B (en) * 1973-06-15 1975-05-28 Upjohn Co Anti-hypertensive compounds
PH22302A (en) * 1985-02-11 1988-07-22 Fujisawa Pharmaceutical Co Piperidine compounds
PT650476E (en) * 1993-04-07 2002-11-29 Otsuka Pharma Co Ltd PERIPHERAL VASODILATING AGENT CONTAINING N-ACILLATED 4-AMINO-PIPERIDINE DERIVATIVES AS ACTIVE INGREDIENTS
MY142362A (en) 2004-01-29 2010-11-30 Otsuka Pharma Co Ltd Pharmaceutical composition for promoting angiogenesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7870M (en) * 1968-11-08 1970-04-27

Also Published As

Publication number Publication date
FR2068477A1 (en) 1971-08-27
BE754587A (en) 1971-02-08
NL166018C (en) 1981-06-15
GB1268469A (en) 1972-03-29
FR2068477B1 (en) 1974-03-22
BR6915179D0 (en) 1973-02-13
DE2034640C3 (en) 1980-06-12
NL7010668A (en) 1971-02-10
DE2034640B2 (en) 1979-09-27
DE2034640A1 (en) 1971-02-11

Similar Documents

Publication Publication Date Title
NL7711042A (en) FENOXY-AMINO PROPANOLS AND METHOD FOR THE PREPARATION THEREOF, AND METHODS FOR PREPARING PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
NL154500B (en) PROCESS FOR THE PREPARATION OF 2-CYCLOHEXENE-1-ON-DERIVATIVES AND HERBICIDE PREPARATIONS CONTAINING THEM.
NL174547B (en) METHOD FOR PREPARING BENZOYLPROPIONIC ACID DERIVATIVES, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND FORMED PHARMACEUTICAL PREPARATIONS.
NL161462C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING SUITABLE COMPOUNDS.
NL7612794A (en) AMINOALCOHOL DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND METHODS FOR PREPARING THEM.
NL164285C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION CONTAINING AN IMIDAZOŸ2.1-BŸTHIAZOLE DERIVATIVE, THE PREPARED PHARMACEUTICAL PREPARATIONS AND A METHOD FOR PREPARING THIS IMIDAZOŸ2.1-BŸTHIAZOLDER
NL172240C (en) METHOD FOR PREPARING PTERIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
NL166018C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, AND FOR PREPARATIONS PREPARED USING THIS PROCESS AND METHOD FOR PREPARING SUITABLE COMPOUNDS.
NL160564C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH CANCEROSTATIC AND IMMUNOSTIMULATING EFFECT, SO PREPARED PREPARED PHARMACEUTICAL PREPARATIONS, AND PROCESS FOR THE PREPARATION OF CANCEROSTATIC OR IMMOBILIZING EFFECTS.
NL7508706A (en) PROCESS FOR THE PREPARATION OF PYRAZOFURINE DERIVATIVES AND PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS.
NL172657C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING USEFUL PYRAZOLOOL3.4-BŸ-PYRIDINE DERIVATIVES
NL180478C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIOBIOTIC ACTION AND METHOD FOR PREPARING RIFAMYCIN COMPOUNDS.
NL7608947A (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATION, FORMED PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING PYRROLIN COMPOUNDS.
NL166471C (en) METHOD FOR PREPARING A THERAPEUTIC PREPARATION AND METHOD FOR PREPARING A SUITABLE BENZOPHEN DERIVATIVE
NL173167C (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS, BASED ON N-ACYLTRYPTOPHANE DERIVATIVES, AND METHOD FOR PREPARING N-ACYLTRYPTOPHANE DERIVATIVES.
NL164552C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION; FORMED PHARMACEUTICAL PREPARATION; METHOD FOR PREPARING MEDICINAL COMPOUNDS.
NL187164C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTI-FERTILITY EFFECT, SO PREPARED PREPARATIONS, AND PROCESS FOR THE PREPARATION OF AROYLPHENYL NAPHALAL COMPOUNDS USED THEREIN.
NL187396C (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING 1-SULFONYL-2-AMINOBENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING 1-SULFONYL-2-AMINOBENZIMIDAZOLE DERIVATIVES, AND PREPARED PREVENTED.
NL175063C (en) PROCESS FOR THE PREPARATION OF 11,11-ALKYLIDE STEROIDS, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND FORMED PHARMACEUTICAL PREPARATIONS.
NL144923B (en) PROCESS FOR THE PREPARATION OF A NALFA-SUBSTITUTED 2-0-METHYLOXYTOCIN DERIVATIVE, PROCESS FOR PREPARING PHARMACEUTICAL AND FORMED PREPARATIONS.
NL168521C (en) PROCESS FOR PREPARING STEROID DERIVATIVES, PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AND FORMED PREPARATION
NL163220C (en) PROCESS FOR PREPARING A CO-R COBAMIDE, AND PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING PREPARED CO-R-COBAMIDE
NL170624C (en) PROCESS FOR PREPARING SUBSTITUTED PHENOXYSALICYLIC ACIDS, PROCESS FOR PREPARING A PHARMACOLOGICAL PREPARATION CONTAINING THESE COMPOUNDS, AND OBTAINING PREPARED PREPARATIONS THEREOF
NL176366C (en) PROCESS FOR PREPARING 4,9,11-TRIESTEROID COMPOUNDS, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AND FORMED PHARMACEUTICAL PREPARATION.
NL183647C (en) METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT USING A MALEOPIMARIC ACID COMPOUND, AND METHOD FOR PREPARING MALEOPIMARIC ACID COMPOUNDS

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee